Argent BioPharma Limited (RGT.L)

GBp 6.0

(-7.69%)

Operating Income Summary of Argent BioPharma Limited

  • Argent BioPharma Limited's latest annual operating income in 2023 was -18.26 Million AUD , down -124.64% from previous year.
  • Argent BioPharma Limited's latest quarterly operating income in 2023 Q4 was -3.49 Million GBP , up 5.12% from previous quarter.
  • Argent BioPharma Limited reported an annual operating income of -8.12 Million AUD in 2022, down -11.12% from previous year.
  • Argent BioPharma Limited reported an annual operating income of -7.31 Million AUD in 2021, down -30.92% from previous year.
  • Argent BioPharma Limited reported a quarterly operating income of -3.68 Million GBP for 2023 Q2, down -3.33% from previous quarter.
  • Argent BioPharma Limited reported a quarterly operating income of -8.12 Million AUD for 2022 FY, down -11.12% from previous quarter.

Annual Operating Income Chart of Argent BioPharma Limited (2023 - 2015)

Historical Annual Operating Income of Argent BioPharma Limited (2023 - 2015)

Year Operating Income Operating Income Growth
2023 -18.26 Million AUD -124.64%
2022 -8.12 Million AUD -11.12%
2021 -7.31 Million AUD -30.92%
2020 -5.58 Million AUD 15.05%
2019 -6.57 Million AUD -31.98%
2018 -4.98 Million GBP -6.54%
2017 -4.67 Million GBP -17.51%
2016 -3.98 Million GBP -190.44%
2015 -1.37 Million GBP 0.0%

Peer Operating Income Comparison of Argent BioPharma Limited

Name Operating Income Operating Income Difference